Phase I/II clinical trial data support the use of bosutinib as second- or third-line tyrosine kinase inhibitor (TKI) therapy in Japanese patients with Philadelphia chromosome-positive (Ph+) chronic ...
Prognostic Significance of Magnetic Resonance Imaging of Femoral Marrow in Patients With Myelodysplastic Syndromes PURPOSE: To evaluate the efficacy of the combination of interferon alpha (IFN-α) and ...
CML Monitor Provides Innovative Method for Tracking Symptoms and Monitoring BCR-ABL Lab Test Results for Physicians and People Living with CML This new app simplifies daily life for people living with ...
Use of nilotinib to induce responses with 24-month (mo) minimum follow-up in patients (pts) with chronic myeloid leukemia in blast crisis (CML-BC) resistant to or intolerant of imatinib. Background: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results